Xiangya Hospital, Central South University, Changsha, PR China.
Department of Orthopedic Surgery, Columbia University, 650 W 168th St, New York, 10032, New York.
J Orthop Res. 2019 Mar;37(3):574-582. doi: 10.1002/jor.24248. Epub 2019 Feb 28.
Intrasynovial tendons are paucicellular and hypovascular, resulting in a poor response to injury. Surgical repair of ruptured or lacerated tendons often lead to complications such as adhesions, repair site gapping, and repair site rupture. Adipose-derived stem cells (ASCs) have shown promise for enhancing tendon repair, as they have the capacity to differentiate into tendon fibroblasts and augment the healing response. Furthermore, connective tissue growth factor (CTGF) has been shown to promote tendon regeneration via the stimulation of endogenous tendon stem cells. Here, we evaluated the potential of CTGF to promote tenogenic differentiation of ASCs in vitro. Gene and protein expression, cell proliferation, and FAK and ERK1/2 signaling were assessed. CTGF increased tenogenic genes in mouse ASCs in a dose- and time-dependent manner. Western blot and immunostaining analyses demonstrated increases in tenogenic protein expression in CTGF-treated ASCs at all timepoints studied. CTGF increased ASC proliferation in a dose-dependent manner. CTGF induced phosphorylation of ERK1/2 within 5 min and FAK within 15 min; both signals persisted for 120 min. Blocking FAK and ERK1/2 pathways by selective inhibitors SCH772984 and PF573228, respectively, attenuated the CTGF-induced tenogenic differentiation and proliferation of ASCs. These results suggest that CTGF induces tenogenic differentiation of ASCs via the FAK and ERK1/2 pathway. Statement of clinical significance: Although prior research has led to advances in tendon operative techniques and rehabilitation methods, clinical outcomes after tendon repair remain variable, with high rates of repair site gapping or rupture. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res.
滑液内肌腱细胞数量少,血管分布稀疏,因此对损伤的反应较差。手术修复破裂或撕裂的肌腱常常导致粘连、修复部位间隙和修复部位破裂等并发症。脂肪来源的干细胞 (ASCs) 在增强肌腱修复方面显示出了很大的潜力,因为它们有能力分化为肌腱成纤维细胞,并增强愈合反应。此外,结缔组织生长因子 (CTGF) 已被证明可以通过刺激内源性肌腱干细胞来促进肌腱再生。在这里,我们评估了 CTGF 促进 ASCs 体外肌腱发生分化的潜力。检测了基因和蛋白表达、细胞增殖以及 FAK 和 ERK1/2 信号。CTGF 以剂量和时间依赖的方式增加了小鼠 ASCs 中的肌腱发生基因。Western blot 和免疫染色分析表明,在所有研究的时间点,CTGF 处理的 ASCs 中肌腱蛋白表达增加。CTGF 以剂量依赖的方式促进 ASC 增殖。CTGF 在 5 分钟内诱导 ERK1/2 的磷酸化,在 15 分钟内诱导 FAK 的磷酸化;这两种信号持续 120 分钟。分别用选择性抑制剂 SCH772984 和 PF573228 阻断 FAK 和 ERK1/2 通路,减弱了 CTGF 诱导的 ASCs 肌腱发生分化和增殖。这些结果表明,CTGF 通过 FAK 和 ERK1/2 通路诱导 ASCs 的肌腱发生分化。临床意义的陈述:尽管先前的研究导致了肌腱手术技术和康复方法的进步,但肌腱修复后的临床结果仍然各不相同,修复部位间隙或破裂的发生率很高。©2019 骨科研究协会。由 Wiley 期刊出版公司出版。J Orthop Res.